As of 1:30 PM on the 4th, Komipharm is trading at 12,800 KRW, up 0.79% from the previous day. This is a decline of 18.47% compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively recorded as net buyers of 20,873 shares. Over the past five days, individual investors have been net sellers of 156,062 shares, while foreigners and institutions have been net buyers of 88,170 shares and 76,810 shares, respectively.


On October 27, Komipharm became an issue in the market with the headline 'New drug "Kominox anticancer effect" confirmed?... Stock price rebounds.'





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing